4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Minervax ApS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants GBS-NN/NN2, Placebo - Group B Streptococcal Infections | Phase 1 | Completed | Minervax ApS | 90 | 2023-03-01 | 2025-09-05 |
| Study to Assess a Booster Dose of GBS-NN/NN2 Vaccine GBS-NN/NN2 - Group B Streptococcus Infection | Phase 1 | Completed | Minervax ApS | 27 | 2021-08-17 | 2024-10-10 |
| Group B Streptococcus Vaccine in Healthy Females GBS-NN/NN2 with Alhydrogel® 25, Placebo GBS-NN/NN2 with Alhydrogel® 25, Placebo GBS-NN/NN2 with Alhydrogel® 50 - Group B Strep Infection | Phase 1 | Completed | Minervax ApS | 60 | 2019-01-09 | 2021-02-02 |
| Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age. GBS-NN vaccine - Infection by Streptococcus Group B | Phase 1 | Completed | Minervax ApS | 240 | 2015-05-01 | 2021-01-14 |
United Kingdom (3) · Belgium (1)
Geoff Kitson (3) · Per Fisher, PM/CEO (1)
2014 (1), 2017 (1)